The breast imaging devices market size has grown strongly in recent years. It will grow from $4.88 billion in 2024 to $5.14 billion in 2025 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to growth in the number of healthcare facilities, economic growth in emerging markets, rapid technological advances, the rising prevalence of breast cancer, and aging female population.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to awareness for early detection of breast diseases, rising use of diagnostic medical imaging, and increasing investment and funding for breast cancer treatments. Major trends in the forecast period include investing in product portfolio expansion, strategic collaboration, and increasing investment in the development of portable devices, investing in photoacoustic breast imaging, augmented reality (AR) for breast imaging, and hybrid imaging technology.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
The rising healthcare expenditure is anticipated to drive the growth of the breast imaging devices market in the future. Healthcare expenditure refers to the total amount of money allocated for healthcare goods and services within a specific region or country over a defined period. This spending encompasses medical consultations, hospital visits, surgeries, diagnostic tests, and treatments. It also includes costs associated with breast cancer screening, diagnosis, and treatment using breast imaging devices, as well as investments in research and development (R&D) for breast imaging technology. For example, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2021. Consequently, the rise in healthcare expenditure is driving the growth of the breast imaging devices market.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
Leading companies in the breast imaging devices market are placing a strong emphasis on AI-driven technology development, exemplified by products such as Imagio. Imagio, introduced by Seno Medical Instruments Inc. in November 2022 and approved by the FDA, is a breast imaging system utilizing opto-acoustic/ultrasound (OA/US) hybrid modality for real-time assessment and differentiation between malignant and benign breast tissue. Capable of detecting tumors as small as 3mm, Imagio incorporates an AI decision-support tool called SenoGram, aiding physicians in interpreting images effectively. This strategic integration of AI technology reflects a commitment to innovation and diagnostic excellence in breast cancer diagnosis.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market include Siemens Healthineers AG, Hologic, Inc., GE Healthcare, FUJIFILM Holdings Corporation, Canon, Philips Healthcare, Aurora Imaging Technology Inc., Delphinus Medical Technologies, Micrima Limited, SonoCine Inc., Hitachi, Ltd., QT Ultrasound LLC, Trivitron Healthcare, Telerad Tech, Henan Forever Medical Co., Ltd., Guangzhou Medsinglong Medical Equipment Co., Ltd., Medsinglong Co Ltd, Toshiba Corporation, Wuhan Darppon Medical Technology Co., Ltd., Planmed Oy, Barco NV, Esaote SpA.
North America was the largest region in the breast imaging devices market in 2024. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
The breast imaging devices market research report is one of a series of new reports that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The breast imaging devices market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to awareness for early detection of breast diseases, rising use of diagnostic medical imaging, and increasing investment and funding for breast cancer treatments. Major trends in the forecast period include investing in product portfolio expansion, strategic collaboration, and increasing investment in the development of portable devices, investing in photoacoustic breast imaging, augmented reality (AR) for breast imaging, and hybrid imaging technology.
The expansion of the breast imaging device market is attributed to the escalating prevalence of breast cancer. Factors such as increased exposure to hormone replacement therapies (HRT), hormonal imbalances, menopause, and several reproductive disorders have significantly elevated the risk of breast cancer among individuals. Breast cancer stands as the most prevalent cancer affecting women globally, as per statistics from the World Health Organization (WHO), impacting approximately 2.1 million women annually. Additionally, it leads to the highest number of cancer-related fatalities among women. A recent report from the American Society of Clinical Oncology (ASCO) indicated that 1 in 3 new female cancer cases in the United States is diagnosed as breast cancer. In the year 2023, an estimated 297,790 women in the United States are expected to be diagnosed with invasive breast cancer and 55,720 with non-invasive (in situ) breast cancer.
The rising healthcare expenditure is anticipated to drive the growth of the breast imaging devices market in the future. Healthcare expenditure refers to the total amount of money allocated for healthcare goods and services within a specific region or country over a defined period. This spending encompasses medical consultations, hospital visits, surgeries, diagnostic tests, and treatments. It also includes costs associated with breast cancer screening, diagnosis, and treatment using breast imaging devices, as well as investments in research and development (R&D) for breast imaging technology. For example, in 2022, the Office for National Statistics, a UK-based national statistics organization, reported that UK healthcare expenditure reached approximately $354.88 billion (£283 billion), representing a nominal increase of 0.7% compared to 2021. Consequently, the rise in healthcare expenditure is driving the growth of the breast imaging devices market.
Leading companies in the breast imaging devices market are concentrating on developing technologically advanced solutions, such as cutting-edge imaging techniques, to enhance early detection and improve diagnostic accuracy for breast cancer. Advanced imaging techniques refer to sophisticated methods that provide detailed and precise visualizations of the body's internal structures, including digital mammography, 3D tomosynthesis, and magnetic resonance imaging (MRI). For example, in October 2024, StoneSprings Hospital Centre, a US-based healthcare facility, introduced new breast imaging technology. This innovative technology employs state-of-the-art imaging modalities, such as digital mammography and 3D tomosynthesis, which deliver clearer and more detailed images of breast tissue. This advancement aids in detecting abnormalities that may not be visible through traditional 2D mammography. The system is designed to incorporate artificial intelligence (AI) algorithms to assist radiologists in more accurately interpreting images. AI can help by flagging potential areas of concern, thereby minimizing the risk of missed diagnoses and enhancing overall accuracy.
Leading companies in the breast imaging devices market are placing a strong emphasis on AI-driven technology development, exemplified by products such as Imagio. Imagio, introduced by Seno Medical Instruments Inc. in November 2022 and approved by the FDA, is a breast imaging system utilizing opto-acoustic/ultrasound (OA/US) hybrid modality for real-time assessment and differentiation between malignant and benign breast tissue. Capable of detecting tumors as small as 3mm, Imagio incorporates an AI decision-support tool called SenoGram, aiding physicians in interpreting images effectively. This strategic integration of AI technology reflects a commitment to innovation and diagnostic excellence in breast cancer diagnosis.
In May 2024, Lunit, a South Korea-based medical AI company specializing in software for cancer screening and treatment, acquired Volpara Health Technologies Limited for an undisclosed amount. Through this acquisition, Lunit aims to enhance its AI-driven cancer diagnostics, expand its presence in the U.S. market, and develop innovative solutions for early cancer detection and improved patient outcomes. Volpara Health Technologies Limited is a New Zealand-based software company that enhances breast imaging devices with cutting-edge software to improve cancer detection.
Major companies operating in the breast imaging devices market include Siemens Healthineers AG, Hologic, Inc., GE Healthcare, FUJIFILM Holdings Corporation, Canon, Philips Healthcare, Aurora Imaging Technology Inc., Delphinus Medical Technologies, Micrima Limited, SonoCine Inc., Hitachi, Ltd., QT Ultrasound LLC, Trivitron Healthcare, Telerad Tech, Henan Forever Medical Co., Ltd., Guangzhou Medsinglong Medical Equipment Co., Ltd., Medsinglong Co Ltd, Toshiba Corporation, Wuhan Darppon Medical Technology Co., Ltd., Planmed Oy, Barco NV, Esaote SpA.
North America was the largest region in the breast imaging devices market in 2024. Asia-Pacific was the second largest market in the global breast imaging devices market report. The regions covered in the breast imaging devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the breast imaging devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
Breast imaging devices are medical equipment crucial for screening, diagnosing, and supporting breast health, including cancerous and noncancerous breast diseases. These devices play a vital role in early detection and treatment of breast cancer.
Key product types in breast imaging devices include tomosynthesis, breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Tomosynthesis is an imaging method employed for both screening and diagnostic purposes, particularly in individuals with or without symptoms of breast cancer. Breast imaging devices utilize ionizing and non-ionizing technologies. These devices find application in hospitals, clinics, breast care centers, and diagnostic imaging centers.
The breast imaging devices market research report is one of a series of new reports that provides breast imaging devices market statistics, including breast imaging devices industry global market size, regional shares, competitors with a breast imaging devices market share, detailed breast imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the breast imaging devices industry. This breast imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The breast imaging devices market consists of sales of imaging equipment such as breast ultrasound, breast MRI, mammography, nuclear imaging, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Breast Imaging Devices Market Characteristics3. Breast Imaging Devices Market Trends and Strategies4. Breast Imaging Devices Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Breast Imaging Devices Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Breast Imaging Devices Market34. Recent Developments in the Breast Imaging Devices Market
5. Global Breast Imaging Devices Growth Analysis and Strategic Analysis Framework
6. Breast Imaging Devices Market Segmentation
7. Breast Imaging Devices Market Regional and Country Analysis
8. Asia-Pacific Breast Imaging Devices Market
9. China Breast Imaging Devices Market
10. India Breast Imaging Devices Market
11. Japan Breast Imaging Devices Market
12. Australia Breast Imaging Devices Market
13. Indonesia Breast Imaging Devices Market
14. South Korea Breast Imaging Devices Market
15. Western Europe Breast Imaging Devices Market
16. UK Breast Imaging Devices Market
17. Germany Breast Imaging Devices Market
18. France Breast Imaging Devices Market
19. Italy Breast Imaging Devices Market
20. Spain Breast Imaging Devices Market
21. Eastern Europe Breast Imaging Devices Market
22. Russia Breast Imaging Devices Market
23. North America Breast Imaging Devices Market
24. USA Breast Imaging Devices Market
25. Canada Breast Imaging Devices Market
26. South America Breast Imaging Devices Market
27. Brazil Breast Imaging Devices Market
28. Middle East Breast Imaging Devices Market
29. Africa Breast Imaging Devices Market
30. Breast Imaging Devices Market Competitive Landscape and Company Profiles
31. Breast Imaging Devices Market Other Major and Innovative Companies
35. Breast Imaging Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Breast Imaging Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on breast imaging devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for breast imaging devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The breast imaging devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Product Type: Tomosynthesis, Breast Ultrasound, Breast Magnetic Resonance Imaging (MRI), Mammography, Nuclear Imaging, Other Product Types2) By Technology: Ionizing, Non Ionizing
3) By End User: Hospitals and Clinics, Breast Care Centers, Diagnostic Imaging Centers
Subsegments:
1) By Tomosynthesis: Digital Breast Tomosynthesis (DBT); 3D Mammography Systems2) By Breast Ultrasound: Handheld Ultrasound; Automated Breast Ultrasound System (ABUS); Elastography
3) By Breast Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI
4) By Mammography: Digital Mammography; Film Mammography; 2D Mammography
5) By Nuclear Imaging: Positron Emission Tomography (PET); Single Photon Emission Computed Tomography (SPECT)
6) By Other Product Types: Infrared Imaging; Molecular Imaging Systems; Stereotactic Breast Biopsy Devices
Key Companies Mentioned: Siemens Healthineers AG; Hologic, Inc.; GE Healthcare; FUJIFILM Holdings Corporation; Canon
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- Siemens Healthineers AG
- Hologic, Inc.
- GE Healthcare
- FUJIFILM Holdings Corporation
- Canon
- Philips Healthcare
- Aurora Imaging Technology Inc.
- Delphinus Medical Technologies
- Micrima Limited
- SonoCine Inc.
- Hitachi, Ltd.
- QT Ultrasound LLC
- Trivitron Healthcare
- Telerad Tech
- Henan Forever Medical Co., Ltd.
- Guangzhou Medsinglong Medical Equipment Co., Ltd.
- Medsinglong Co Ltd
- Toshiba Corporation
- Wuhan Darppon Medical Technology Co., Ltd.
- Planmed Oy
- Barco NV
- Esaote SpA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 5.14 Billion |
| Forecasted Market Value ( USD | $ 6.86 Billion |
| Compound Annual Growth Rate | 7.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
